Skip to main content

EU promises speedy review of remdesivir

The European health regulator has vowed to conduct a speedy review of Gilead Sciences' potential COVID-19 drug, remdesivir, but says it has not yet received an application from the US drugmaker.

from Breaking News | Daily Telegraph https://ift.tt/3dfAW2l
Labels:

Comments

Post a Comment

Popular posts from this blog

20 Killed in Israeli Strikes as Israel and Hamas Trade Blame Over Truce

By Aaron Boxerman and Saher Alghorra from NYT World https://ift.tt/OzFTSBp
Post a Comment
Read more

LimeWire, Former File-Sharing Service, Is Revealed as Buyer of Fyre Festival

By Sopan Deb from NYT U.S. https://ift.tt/mO53Eit
Post a Comment
Read more

2025 Holiday Gift Guide

By Unknown Author from NYT U.S. https://ift.tt/V26QqEs
Post a Comment
Read more